The settlement covers consumers who purchased Differin Daily Deep Cleanser (5% benzoyl peroxide), Differin Acne Spot Treatment (10% benzoyl peroxide), or Differin Maximum Strength Acne Foaming Cleanser (10% benzoyl peroxide) between Jan. 1, 2020 and Feb. 19, 2026. Plaintiffs claim Differin did not disclose potential benzene contamination in these acne products. Benzene is a human carcinogen linked to leukemia and other blood disorders. Differin is a Galderma Laboratories brand sold at retailers including Walmart, Walgreens, and CVS.